Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
NCT01202747
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Chalazion
Dry Eye Syndromes
Interventions
DEVICE:
LipiFlow System
Sponsor
TearScience, Inc.